Pyridazinonderivate

European patent · EP2754660 · In force

Register entry

Publication number
EP2754660
Application number
EP14001269
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 29, 2008
Published
Jul 16, 2014
Granted
Nov 2, 2016
Protection ends at the latest
Apr 28, 2028
Next annual fee due
Apr 30, 2027
IPC classes
A61K 31/506 (2006.01)
A61K 31/5355 (2006.01)
A61K 31/55 (2006.01)
A61K 31/5377 (2006.01)
A61P 35/00 (2006.01)
A61K 31/501 (2006.01)
A61K 9/00 (2006.01)
C07D 453/02 (2006.01)
A61K 45/06 (2006.01)
C07D 405/14 (2006.01)
C07D 417/10 (2006.01)
C07D 409/14 (2006.01)
C07D 451/06 (2006.01)
C07D 417/14 (2006.01)
C07D 401/14 (2006.01)
C07D 403/10 (2006.01)
C07D 401/10 (2006.01)
A61K 9/28 (2006.01)
A61K 9/08 (2006.01)
Priority
DE 102007032507 12.07.2007
Divided from
EP08758359
Filing language
German
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  5. Nov 2, 2016

    Granted

    Published in Swissreg on 02.11.2016

Parties

Holder

Merck Patent GmbH

Frankfurter Strasse 250, 64293 Darmstadt, DE

Inventor

Dorsch, Dieter

64372 Ober-Ramstadt, DE

Stieber, Frank

64683 Einhausen, DE

Schadt, Oliver

63517 Rodenbach, DE

Blaukat, Andree

64342 Seeheim-Jugenheim, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.